The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction

Chongqing Medical University1,000 enrolled

Overview

The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Acute Coronary Syndrome

Interventions

beta-blockerDRUG

To investigate the relationship between the use of beta blockers and prognosis in patients with normal ejection fraction after acute myocardial infarction

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The diagnosis of acute myocardial infarction was clear and the left ventricular ejection fraction was normal Exclusion Criteria: * History of heart failure Died in hospital

Locations (1)

The first affiliated Hospital of Chongqing Medical University

Chongqing, China

RECRUITING

Outcomes

Primary Outcomes

mortality

all-cause mortality

Time frame: the median time of 8 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.